Carlos Alberto Velasco-Benitez, Steven Koremblun Murillo, Claudia Jimena Ortíz-Rivera, Edgar Játiva Mariño, Fátima Azereth Reynoso Zarzosa, Mariana Xail Espriu Ramírez, Jorge Alberto Macías-Flores, Roberto Arturo Zablah Córdova, Ricardo A. Chanis Águila, Trini Fragoso Arbelo, Milton Danilo Mejía Castro, Yunuen Rivera Suazo
Introducción. La prevalencia de regurgitación infantil en niños latinoamericanos está entre el 8% y el 9,4% según los criterios de Roma III. Objetivo. Determinar la prevalencia de regurgitación infantil en niños latinoamericanos según los criterios de Roma IV y sus posibles asociaciones. Materiales y métodos. Estudio observacional, descriptivo, de prevalencia, realizado en siete países latinoamericanos. Se utilizó la base de datos de la Functional International Digestive Epidemiological Research Survey para seleccionar la muestra. Se incluyeron en el estudio niños menores de 12 meses que fueron diagnosticados con regurgitación infantil mediante el Cuestionario de Síntomas Gastrointestinales Pediátricos Roma IV. Resultados. Se analizaron 1802 lactantes (80,7% de América del Sur; 6,7±3,8 meses de edad). Se diagnosticó regurgitación infantil en 6,8% (52,5% mujeres; 39,8% mestizos; 46,7% colombianos). La edad pico fue 6 meses de vida. Hubo mayor probabilidad de presentar regurgitación infantil en los lactantes entre 1 y 6 meses de edad, de raza indígena, de Centroamérica, nacidos por cesárea, prematuros, atendidos en instituciones públicas, por gastroenterólogos pediatras y durante la pandemia del Covid-19. Hubo menor probabilidad de presentar regurgitación infantil en los lactantes con alimentación complementaria. Conclusión. La regurgitación infantil es frecuente en lactantes latinoamericanos. La prevalencia es menor comparativamente a lo descripto en otros países, con factores de riesgo como raza, origen, cesárea, prematuridad, sitio y nivel de atención, y pandemia de COVID-19. El factor protector es la alimentación complementaria.
{"title":"Prevalencia de regurgitación infantil: experiencia del grupo de trabajo en trastornos del eje cerebro-intestino de la Sociedad Latinoamericana de Gastroenterología, Hepatología y Nutrición Pediátrica (SLAGHNP)","authors":"Carlos Alberto Velasco-Benitez, Steven Koremblun Murillo, Claudia Jimena Ortíz-Rivera, Edgar Játiva Mariño, Fátima Azereth Reynoso Zarzosa, Mariana Xail Espriu Ramírez, Jorge Alberto Macías-Flores, Roberto Arturo Zablah Córdova, Ricardo A. Chanis Águila, Trini Fragoso Arbelo, Milton Danilo Mejía Castro, Yunuen Rivera Suazo","doi":"10.52787/agl.v53i1.280","DOIUrl":"https://doi.org/10.52787/agl.v53i1.280","url":null,"abstract":"Introducción. La prevalencia de regurgitación infantil en niños latinoamericanos está entre el 8% y el 9,4% según los criterios de Roma III. Objetivo. Determinar la prevalencia de regurgitación infantil en niños latinoamericanos según los criterios de Roma IV y sus posibles asociaciones. Materiales y métodos. Estudio observacional, descriptivo, de prevalencia, realizado en siete países latinoamericanos. Se utilizó la base de datos de la Functional International Digestive Epidemiological Research Survey para seleccionar la muestra. Se incluyeron en el estudio niños menores de 12 meses que fueron diagnosticados con regurgitación infantil mediante el Cuestionario de Síntomas Gastrointestinales Pediátricos Roma IV. Resultados. Se analizaron 1802 lactantes (80,7% de América del Sur; 6,7±3,8 meses de edad). Se diagnosticó regurgitación infantil en 6,8% (52,5% mujeres; 39,8% mestizos; 46,7% colombianos). La edad pico fue 6 meses de vida. Hubo mayor probabilidad de presentar regurgitación infantil en los lactantes entre 1 y 6 meses de edad, de raza indígena, de Centroamérica, nacidos por cesárea, prematuros, atendidos en instituciones públicas, por gastroenterólogos pediatras y durante la pandemia del Covid-19. Hubo menor probabilidad de presentar regurgitación infantil en los lactantes con alimentación complementaria. Conclusión. La regurgitación infantil es frecuente en lactantes latinoamericanos. La prevalencia es menor comparativamente a lo descripto en otros países, con factores de riesgo como raza, origen, cesárea, prematuridad, sitio y nivel de atención, y pandemia de COVID-19. El factor protector es la alimentación complementaria.","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135419737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Buenas prácticas endoscópicas surgidas de la actividad conjunta SAGE-ENDIBA 2019 y los indicadores de calidad en endoscopía de ASGE","authors":"Laudanno Om","doi":"10.52787/QCAJ6371","DOIUrl":"https://doi.org/10.52787/QCAJ6371","url":null,"abstract":"","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48192556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
right hemicolectomy with transverse ileus anastomosis, but if the volvulus caused intestinal necrosis and the patient is hemodynamically unstable, it is safer to perform intestinal resection and ileostomy. Ascending ileus anastomosis performed at a higher level of the ascending colon is a safe alterna-tive for the restitution of intestinal transit in patients with cecal volvulus.
{"title":"Vólvulo de ciego con lesión de colon ascendente reporte de un caso y alternativas de tratamiento","authors":"G. Sosa, A. Barrios","doi":"10.52787/SUYI2286","DOIUrl":"https://doi.org/10.52787/SUYI2286","url":null,"abstract":"right hemicolectomy with transverse ileus anastomosis, but if the volvulus caused intestinal necrosis and the patient is hemodynamically unstable, it is safer to perform intestinal resection and ileostomy. Ascending ileus anastomosis performed at a higher level of the ascending colon is a safe alterna-tive for the restitution of intestinal transit in patients with cecal volvulus.","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43793390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tatiana Uehara, Harumi Hashimoto, Federico Bazán, Adriana Tévez, Gladys Bravo, S. Schaab, J. Sordá
Background and aims. The appropriate diagnosis of irritable bowel syndrome is critical due to its association with impaired quality of life and high health care costs. We aim to explore the proportion of subjects with irritable bowel syndrome by the Rome IV criteria at a tertiary care center and compare them with previous diagnostic criteria. Material and methods. We conducted a cross-sectional descriptive study in a tertiary care center located in Buenos Aires. There were included to the consecutive adult patients who consulted for abdominal disorders and in whom an organic pathology had been excluded. Subjects completed a gastrointestinal symptom questionnaire and the proportion of patients with IBS, according to Roma IV criteria, was compare with the proportion of those who met the previous criteria (Manning, Rome I, II and III). Results. Of 178 patients included, 58% met the diagnosis criteria for IBS using the Rome IV criteria. Of these, 98% were also Rome III positive, 76.7% IBS Rome II positive, 93% IBS Rome I positive and 99% IBS Manning positive. The agreement was very good with Rome III (kappa = 0.87), good with Rome I (kappa = 0.76) and good, but lower with Rome II (kappa = 0.73) and Manning (kappa = 0.66). Conclusions. Good diagnostic agreement was established between Rome IV and the previous IBS criteria, except with Rome II and Manning, which were lower.
{"title":"Comparación entre los criterios diagnósticos del síndrome de intestino irritable en una población latinoamericana. Estudio descriptivo de un centro de atención terciaria","authors":"Tatiana Uehara, Harumi Hashimoto, Federico Bazán, Adriana Tévez, Gladys Bravo, S. Schaab, J. Sordá","doi":"10.52787/NDNI4913","DOIUrl":"https://doi.org/10.52787/NDNI4913","url":null,"abstract":"Background and aims. The appropriate diagnosis of irritable bowel syndrome is critical due to its association with impaired quality of life and high health care costs. We aim to explore the proportion of subjects with irritable bowel syndrome by the Rome IV criteria at a tertiary care center and compare them with previous diagnostic criteria. Material and methods. We conducted a cross-sectional descriptive study in a tertiary care center located in Buenos Aires. There were included to the consecutive adult patients who consulted for abdominal disorders and in whom an organic pathology had been excluded. Subjects completed a gastrointestinal symptom questionnaire and the proportion of patients with IBS, according to Roma IV criteria, was compare with the proportion of those who met the previous criteria (Manning, Rome I, II and III). Results. Of 178 patients included, 58% met the diagnosis criteria for IBS using the Rome IV criteria. Of these, 98% were also Rome III positive, 76.7% IBS Rome II positive, 93% IBS Rome I positive and 99% IBS Manning positive. The agreement was very good with Rome III (kappa = 0.87), good with Rome I (kappa = 0.76) and good, but lower with Rome II (kappa = 0.73) and Manning (kappa = 0.66). Conclusions. Good diagnostic agreement was established between Rome IV and the previous IBS criteria, except with Rome II and Manning, which were lower.","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49534602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diana Marcela Rodríguez De La Hoz, M. Alvarez, M. Orozco, María De Vedia, Nicolás Roccatagliata, R. Cobeñas, N. Larrañaga
{"title":"Hallazgo incidental postrauma abdominal","authors":"Diana Marcela Rodríguez De La Hoz, M. Alvarez, M. Orozco, María De Vedia, Nicolás Roccatagliata, R. Cobeñas, N. Larrañaga","doi":"10.52787/XORO6319","DOIUrl":"https://doi.org/10.52787/XORO6319","url":null,"abstract":"","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"51 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42124253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Bello, N. Larrañaga, G. Espil, S. Kozima, Fabiana Prado
{"title":"Solución del caso. Complicación posretrasplante hepático","authors":"M. Bello, N. Larrañaga, G. Espil, S. Kozima, Fabiana Prado","doi":"10.52787/ZPRY7802","DOIUrl":"https://doi.org/10.52787/ZPRY7802","url":null,"abstract":"","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48151392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
María del Mar Roldán Alcázar, A. M. Maldonado, A. S. Gutiérrez, C. Cejudo
{"title":"Hallazgo radiológico infrecuente por una hiperpresión abdominal tras un traumatismo","authors":"María del Mar Roldán Alcázar, A. M. Maldonado, A. S. Gutiérrez, C. Cejudo","doi":"10.52787/HMYJ6165","DOIUrl":"https://doi.org/10.52787/HMYJ6165","url":null,"abstract":"","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46935418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bryan Cuzcano Villalobos, Kevin Quinteros Figueroa, Jorge Enrique Osada Liy
{"title":"Importancia de la clasificación de obesidad en la tasa de erradicación de Helicobacter pylori","authors":"Bryan Cuzcano Villalobos, Kevin Quinteros Figueroa, Jorge Enrique Osada Liy","doi":"10.52787/VFOY2155","DOIUrl":"https://doi.org/10.52787/VFOY2155","url":null,"abstract":"","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47608233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. D. Bosia, María Virginia D´Ascenzo, Silvia Borzi, E. Barán, María Cecilia Calzona
The development of new direct acting antiviral drugs for the treatment of Hepatitis C virus infection, has made it possible to obtain an excellent cure rate and extend the indications for eradication of Hepatitis C virus to previously very difficult populations to treat like cystic fibrosis, in whom treatment with classic regimens based on pegylated Interferon plus ribavirin could favor worsening lung function. We present a case of a 41-year-old man with cystic fibrosis, diagnosed with Hepatitis C virus infection, genotype 1a, non-cirrhotic, treated with direct acting antiviral drugs for twelve weeks, obtaining a sustained viral response, without adverse effects. One year later, being on the waiting list, underwent a bipulmonary transplant.
{"title":"Tratamiento de hepatitis crónica por virus de Hepatitis C con drogas antivirales de acción directa en un paciente con fibrosis quística","authors":"J. D. Bosia, María Virginia D´Ascenzo, Silvia Borzi, E. Barán, María Cecilia Calzona","doi":"10.52787/TZDH9217","DOIUrl":"https://doi.org/10.52787/TZDH9217","url":null,"abstract":"The development of new direct acting antiviral drugs for the treatment of Hepatitis C virus infection, has made it possible to obtain an excellent cure rate and extend the indications for eradication of Hepatitis C virus to previously very difficult populations to treat like cystic fibrosis, in whom treatment with classic regimens based on pegylated Interferon plus ribavirin could favor worsening lung function. We present a case of a 41-year-old man with cystic fibrosis, diagnosed with Hepatitis C virus infection, genotype 1a, non-cirrhotic, treated with direct acting antiviral drugs for twelve weeks, obtaining a sustained viral response, without adverse effects. One year later, being on the waiting list, underwent a bipulmonary transplant.","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71004760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：